Precision BioSciences (FRA:PBS0) Accounts Payable & Accrued Expense : €1.65 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Precision BioSciences Accounts Payable & Accrued Expense?

Precision BioSciences's quarterly accounts payable & accrued expense increased from Sep. 2023 (€1.87 Mil) to Dec. 2023 (€4.15 Mil) but then declined from Dec. 2023 (€4.15 Mil) to Mar. 2024 (€1.65 Mil).

Precision BioSciences's annual accounts payable & accrued expense declined from Dec. 2021 (€4.58 Mil) to Dec. 2022 (€2.34 Mil) but then increased from Dec. 2022 (€2.34 Mil) to Dec. 2023 (€4.15 Mil).

Precision BioSciences Accounts Payable & Accrued Expense Historical Data

The historical data trend for Precision BioSciences's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Precision BioSciences Accounts Payable & Accrued Expense Chart

Precision BioSciences Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

3.99

3.34

4.58

2.34

4.15

Precision BioSciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															2.92	2.83	1.87	4.15	1.65

Precision BioSciences Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Precision BioSciences (FRA:PBS0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Precision BioSciences Inc (FRA:PBS0) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

DTIL:USA

Address

302 East Pettigrew Street, Dibrell Building, Suite A-100, Durham, NC, USA, 27701

Website

https://www.precisionbiosciences.com

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.

Precision BioSciences (FRA:PBS0) Headlines

No Headlines